CORSODYL MOUTHWASH

Land: Israël

Taal: Engels

Bron: Ministry of Health

Koop het nu

Download Bijsluiter (PIL)
24-11-2023
Download Productkenmerken (SPC)
20-01-2021

Werkstoffen:

CHLORHEXIDINE DIGLUCONATE

Beschikbaar vanaf:

GSK CONSUMER HEALTHCARE, ISRAEL LTD

ATC-code:

A01AB03

farmaceutische vorm:

SOLUTION

Samenstelling:

CHLORHEXIDINE DIGLUCONATE 0.2 %W/V

Toedieningsweg:

LOCAL ORAL

Prescription-type:

Not required

Geproduceerd door:

PURNA PHARMACEUTICALS, BELGIUM

Therapeutische categorie:

CHLORHEXIDINE

Therapeutisch gebied:

CHLORHEXIDINE

therapeutische indicaties:

Antibacterial solution for the disinfection of the mouth.1. As an aid to maintaining oral hygiene.2. As an aid in the treatment and prevention of gingivitis.3. Inhibition of formation of dental plaque.4. For use in aphtous ulceration and oral candidal infections (eg denture stomatitis and thrush).5. For use in a post- periodontal surgery or treatment regimen to promote gingival healing.

Autorisatie datum:

2019-08-31

Bijsluiter

                                2017 (
) – 1986
: 0.2% W/V
CHLORHEXIDINE DIGLUCONATE 0.2% W/V
6.
.
.
,
.
12
.
12
,
.
.
,
.
1.
?
•
•
(
)
•
•
,
•
,
,
,
: А
2.
,
.
• 12
,
.
•
.
.
-
,
.
•
.
“
”.
•
.
“
”
.
•
,
.
•
.
“
”.
•
,
.
“
”.
,
,
,
,
.
,
.
.
3.
?
,
.
,
.
.
.
.
5
,
,
.
.
:
.
10
.
,
.
:
. (
)
:
2
.
:
15 .
:
.
,
.
!
.
.
4.
,
.
.
,
.
,
,
,
.
Э
,
.
,
,
.
,
: . Э
.
.
.
,
,
–
,
(
.
“
”).
,
.
.
,
,
,
.
.
–
.
,
.
,
“
”,
(www.health.gov.il)
,
,
:
https://sideeffects.health.gov.il/
,
,
,
,
,
.
5.
?
! Э
,
,
,
/
,
.
.
(exp. date),
.
.
+25º
. 6
.
6.
, -
Purified water, Sorbitol, Glycerol, Macrogolglycerol hydroxystearate
and Optamint 291616
flavour. -
,
,
.
,
300
.
: GSK
.,
/ 3256,
.
:
GmbH & Co. KG,
,
.
2014.
2017,
: 029-96-21599
GSK.
©2019
GSK
.
_Cor MW PT v7a_
_ _
                                
                                Lees het volledige document
                                
                            

Productkenmerken

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Corsodyl 0.2% Mouthwash
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Chlorhexidine Digluconate 0.2% w/v
(equivalent to Chlorhexidine Digluconate Solution 1.028% w/w)
Also contains macrogolglycerol hydroxystearate. For a full list of
excipients,
see section 6.1.
3.
PHARMACEUTICAL FORM
Oromucosal solution
A clear to slightly opalescent, transparent solution with an odour of
peppermint.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Antibacterial solution for the disinfection of the mouth.
1. As an aid to maintaining oral hygiene.
2. As an aid in the treatment and prevention of gingivitis.
3. Inhibition of formation of dental plaque.
4. For use in aphtous ulceration and oral candidal infections (eg
denture
stomatitis and thrush).
5. For use in a post- periodontal surgery or treatment regimen to
promote
gingival healing.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults:
Thoroughly rinse the mouth for about one minute with 10 ml twice
daily. Spit
out after use. In the dental surgery, the patient should be instructed
to rinse the
mouth for one minute prior to treatment.
For the treatment of gingivitis, a course of about one month is
advisable
although some variation in response is to be expected. In the case of
aphthous
ulceration and oral candidal infections treatment should be continued
for 48
hours after clinical resolution. For the treatment of dental
stomatitis, the
dentures should be cleansed and soaked in Corsodyl 0.2% Mouthwash for
fifteen minutes twice daily.
Do not exceed the stated dose.
Children and the Elderly:
The normal adult dose is appropriate for elderly patients and children
of 12 years
and over unless otherwise recommended by the dentist or the physician.
Children under 12 years of age should not use the product unless
recommended
by a healthcare professional.
Route of administration
Oromucosal use. [This product is not intended to be swallowed].
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the exc
                                
                                Lees het volledige document
                                
                            

Documenten in andere talen

Bijsluiter Bijsluiter Arabisch 24-11-2023
Bijsluiter Bijsluiter Hebreeuws 26-11-2017

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten